Log in to save to my catalogue

Assessment of circulating tumor DNA in patients with locally advanced rectal cancer treated with neo...

Assessment of circulating tumor DNA in patients with locally advanced rectal cancer treated with neo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_197e169f752440c5991a9a45abdaf52b

Assessment of circulating tumor DNA in patients with locally advanced rectal cancer treated with neoadjuvant therapy

About this item

Full title

Assessment of circulating tumor DNA in patients with locally advanced rectal cancer treated with neoadjuvant therapy

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-11, Vol.14 (1), p.29536-9, Article 29536

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Post-neoadjuvant therapy (post-NAT) and post-surgical circulating tumor DNA (ctDNA) risk stratification may enhance the management of patients with locally advanced rectal cancer (LARC). In this study, we assessed the prognostic value of ctDNA-based MRD detection in LARC patients using a personalized, tumor-informed ctDNA assay. Plasma samples from...

Alternative Titles

Full title

Assessment of circulating tumor DNA in patients with locally advanced rectal cancer treated with neoadjuvant therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_197e169f752440c5991a9a45abdaf52b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_197e169f752440c5991a9a45abdaf52b

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-80855-8

How to access this item